Andrew Artenstein to Anthrax
This is a "connection" page, showing publications Andrew Artenstein has written about Anthrax.
Connection Strength
1.176
-
Artenstein AW, Opal SM. Novel approaches to the treatment of systemic anthrax. Clin Infect Dis. 2012 Apr; 54(8):1148-61.
Score: 0.399
-
Artenstein AW. Anthrax: from antiquity to answers. J Infect Dis. 2007 Feb 15; 195(4):471-3.
Score: 0.277
-
Artenstein AW, Opal SM, Cristofaro P, Palardy JE, Parejo NA, Green MD, Jhung JW. Chloroquine enhances survival in Bacillus anthracis intoxication. J Infect Dis. 2004 Nov 01; 190(9):1655-60.
Score: 0.237
-
Opal SM, Lim YP, Cristofaro P, Artenstein AW, Kessimian N, Delsesto D, Parejo N, Palardy JE, Siryaporn E. Inter-a inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock. 2011 Jan; 35(1):42-4.
Score: 0.091
-
Artenstein AW. Biodefense: medicine in the time of bioterrorism. Med Health R I. 2003 Jul; 86(7):201-3.
Score: 0.054
-
Artenstein AW, Neill MA, Opal SM. Bioterrorism and physicians. Ann Intern Med. 2002 Oct 01; 137(7):626.
Score: 0.052
-
Artenstein AW, Neill MA, Opal SM. Bioterrorism and physicians. Med Health R I. 2002 Feb; 85(2):74-6.
Score: 0.049
-
Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication. Infect Immun. 2005 Aug; 73(8):5101-5.
Score: 0.016